amfAR, The Foundation for AIDS Research

Dr. Krim rotator.jpg

amfAR Mourns

An inspirational and beloved leader, Dr. Krim made an extraordinary impact on the fight against AIDS.



Research News T-Cell image
Cancer Gene Therapy Strategy Suppresses HIV in Lab Study

The first FDA-approved gene therapy treatment for cancer patients has shown promise in suppressing HIV infection long term in lab monkeys, according to a study partially funded by amfAR.


Dolute Image
HIV Treatment Clinical Brief: Dolutegravir

Dolutegravir (DTG) is a well-tolerated antiretroviral drug that is increasingly recognized as a potential first-line option for the treatment of HIV. This clinical brief is available in English, Bahasa Indonesia, Chinese Mandarin, Japanese, Khmer, Korean, Malay, Thai and Vietnamese.

Other News and Features

amfAR’s Greg Millett Honored by HIV Plus Magazine

Greg Millett, amfAR Vice President and Director of Public Policy, has been ranked #4 on HIV Plus magazine’s 20 Most Amazing HIV+ People of 2018.

"Pathways to Progress: Combating the HIV/AIDS Epidemic"

The Washington Post convened some of the country’s top health officials, practitioners, thought leaders and advocates for a discussion about the ongoing HIV/AIDS crisis in America.
Op-Ed: There Is No Place for Complacency in the Fight Against AIDS

In an op-ed for World AIDS Day, amfAR CEO Kevin Robert Frost tells Mediaplanet why complacency can be deadly in the prevention and treatment of HIV/AIDS.


Upcoming EventsView All
Past EventsView All

Apply & Participate

Connect with us!

amazon smile png

Benefit amfAR While You Shop on Amazon
If you shop at AmazonSmile, you can benefit amfAR with every purchase—at no cost to you!

    Charity Navigator 2bbblogosmall

  • Bold
  • Delta
  • Kiehls
  • Moet
  • Moncler
  • Renault
  • Cadillac
  • MAC
  • AMTD